MHC Ebola Communication

MHC Ebola Communication

By: Mölnlycke Health Care, November 24 2014Posted in: MHC Ebola Communication

To All of Our Valued Customers:

The outbreak of the Ebola virus in several West African countries, which has escalated with an increasing number of suspected, probable and confirmed cases, is now starting to cause concern globally. Naturally this has implications for the wider healthcare and medical community, and has given rise to many questions.

What we do know about Ebola is that human-to-human virus transmission occurs from direct contact through broken skin or mucous membranes with the blood or other bodily fluids or secretions (stool, urine, saliva, semen) of infected people. Given the methods of transmission, general guidelines from organizations, such as the World Health Organization (WHO) and Centers for Disease Control (CDC), have emphasized infection prevention and control measures that healthcare facilities and professionals engage in already. Beyond that, the WHO has issued written guidelines1 that include recommendations for personal protection equipment when caring for patients infected with (or suspected to be infected with) the Ebola virus. These guidelines should be referred to first and foremost.

While Mölnlycke Health Care has not tested its products specifically for use in protection in treating patients infected with Ebola, we do offer products that are designed to fulfill infection control and barrier protection purposes, such as surgical gloves, gowns, face masks and so forth. For more detailed information on products fulfilling these needs, see the information below, where we have provided a range of products made from impermeable or fluid-repellant material, which protect against microorganism transfer, body fluids and particles.

Your local Mölnlycke Health Care representative will be happy to assist you with product information and availability questions.

It is important to clarify that Mölnlycke Health Care offers no products that have been tested specifically against the Ebola virus.

 Biogel surgical gloves

Biogel PI indicator Underglove and            Biogel PI Ultratouch or Biogel PI

 416 and (411 or 408)

Biogel Skinsense Underglove and Biogel Skinsense

 406 and 314


 Face masks and eye protection

 BARRIER N95 particulate respirator

 4272, 4273

 BARRIER protective goggles


 BARRIER protective glasses



Shri P. Parikh
Mölnlycke Health Care
VP, Surgical and Corporate Accounts



More information and references:

  1. WHO, Interim Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-Care Settings, with Focus on Ebola:
  2. WHO, Frequently answered questions regarding Ebola:
  3. Centers of Disease Control (CDC), US:
  4. Department of Health, HSE and Advisory committee on dangerous pathogens, UK:
  5. The National Board of Health and Welfare (Socialstyrelsen, Sweden):

Pathogen safety data sheet- infectious substances, Public Health Agency of Canada Canada:

Please Note:  Use of protective apparel is only a single component of a comprehensive personal protective equipment (PPE) program recommended for response to the Ebola virus disease.  The information provided herein is not intended as a substitute for end-users performance of individual hazard assessments to determine the suitability of Mölnlycke Health Care products for their particular purpose.  It is provided as information only, and not as a product recommendation.

Share this

New & updated

More from the same category